Overview

Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes

Status:
NOT_YET_RECRUITING

Trial end date:
2032-11-01

Target enrollment:

Participant gender:

Summary

Long-Term Study to Evaluate the Safety and Efficacy in Participants with Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes (EPICS-V)

Phase:

PHASE3

Details

Lead Sponsor:

Zydus Therapeutics Inc.

Treatments:

saroglitazar